AbCellera Biologics Inc. (ABCL)

7.34 +0.03 (+0.41%) At close: 04:00PM EDT

AbCellera Biologics Inc.

2215 Yukon Street
Vancouver, BC V5Y 0A1
Canada

https://www.abcellera.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 475

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Carl L.G. Hansen Ph.D.	CEO, Pres & Chairperson	616.66k	2.77M	1975
Mr. Andrew Booth M.B.A.	Chief Financial Officer	563.57k	37.12M	1974
Dr. Veronique Lecault Ph.D.	COO & Director	563.57k	13.19M	1985
Mr. Tryn T. Stimart Esq., J.D.	Chief Legal Officer, Chief Compliance Officer & Corp. Sec.	563.8k	24.68M	1970
Dr. Ester Falconer Ph.D.	Chief Technology Officer	N/A	N/A	1975
Mr. Bo Barnhart Ph.D.	Scientific Director	N/A	N/A	N/A
Ms. Tiffany Chiu B.Sc., Ph.D.	VP of Communications	N/A	N/A	N/A
Alexandra Weirich M.Sc.	Mang. of Marketing & Communications	N/A	N/A	N/A
Graham Craig M.Sc.	Director of Corp. Devel.	N/A	N/A	N/A
Caitlin Webster CIPD, M.Sc.	Sr. Mang. of People & Culture	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Corporate governance

AbCellera Biologics Inc.’s ISS governance QualityScore as of 1 February 2023 is 8. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.